2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards

Abstract

Revision, Clinical Modification MIS multisystem inflammatory syndrome MRI magnetic resonance imaging NCDR National Cardiovascular Data Registry PASC postacute sequelae of SARS-CoV-2 infection PPE protective personal equipment SARS-CoV-2 severe acute respiratory syndrome-coronavirus-2 2. METHODOLOGY 2.1. Writing Committee Composition The Task Force selected the members of this writing committee. The writing committee consisted of 15 individuals with domain expertise in cardiomyopathy, infectious disease, CVD, myocarditis, cardiovascular registries, outcomes assessment, medical informatics, health information management, and health care services research and delivery.

An electrophysiological substrate of COVID-19

“…The study investigators manually reviewed eligible electronic medical records (EMR) and collected detailed information on patient demographic characteristics, past medical history and medications, COVID-19 symptoms and treatment, ECG, and echocardiogram measurements, in accordance with the definitions and timeline of COVID-19 episodes. The data have been harmonized according to the 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19 [ 5 ]. Healthy status was determined in absence of any medical history in the EMR, if there were documented annual check-ups.…”

“…Satisfactory reproducibility of the GEH measurement has been previously confirmed for NS, AF, and VP median beats [ 7 ]. Clinical 12‑lead ECG data elements [ 5 ] (rhythm, heart rate, ventricular conduction abnormalities, AV block, ST-segment changes, abnormal Q-waves) were collected.…”

COVID-19 Infections in Adults with Congenital Heart Disease—A Prospective Single-Center Study in an Outpatient Setting

“…Analysis of ventricular volumes, paramagnetic mapping, and LGE was performed by using CVI42 ® (Circle Cardiovascular Imaging Inc., Calgary, AB, Canada). A myocardial involvement was defined according to current recommendations: myocardial edema by T2 mapping or T2-weighted imaging, myocardial injury by T1 mapping, myocardial injury by late gadolinium enhancement, pericardial changes, new ventricular function abnormalities, or other new cardiac structural abnormalities [ 16 ].…”

A Post-Pandemic Enigma: The Cardiovascular Impact of Post-Acute Sequelae of SARS-CoV-2

“…Finally, invasive cardiac testing such as coronary angiography, endomyocardial biopsy, and electrophysiology studies may be performed depending upon initial cardiac diagnostic study results and suspicion of coronary disease, myocardial disease, and arrhythmogenic disease. 136 , 137 …”

“…Therapeutic anticoagulation for diagnosed thromboembolic disease is advised while prophylactic anticoagulation in an outpatient setting may pose greater risk than benefit and should be dependent upon individual risk and comorbidities. 136 , 137 …”